Industry NewsInSphero and Hamilton have announced collaboration to improve the production and handling of spheroids using advanced liquid handling technology
Product NewsInSphero Launches Industry’s First Automation-Compatible 3D Human Liver Disease Platform for NASH Drug Discovery and Screening
Industry NewsInSphero Announces Collaboration with NIH NCATS to Accelerate Development of Physiologically Relevant 3D Models for Anti-Cancer Drug Screening
Product NewsInSphero Launches Multi-Donor Human Liver Microtissues for Prediction of Drug-Induced Liver Injury
Industry NewsInSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual
Product NewsInSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting
Product NewsInSphero Launches Enhanced Ultra-low Attachment Spheroid Plate for Scaffold-free 3D Cell Culture
Product NewsProtea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues
Industry NewsInSphero Announces Collaboration with NIH National Center for Advancing Translational Sciences (NCATS)
Product NewsJBS Publication Demonstrates Utility of InSphero 3D Co-culture Microtissues as Phenotypic RNAi Screening Tool
Product NewsInSphero Study Reveals Enhanced Stress-Responsive & Metabolic Gene Expression in 3D Liver Microtissues
Industry NewsInSphero Hires New Director of Global Marketing to Help Inform the Life Sciences Community about 3D-Cell-Based Assays
Product NewsCyprotex to Offer New Long-Term Toxicity Testing Service Using InSphero 3D InSight Liver Microtissues
